<div id="readability-page-1"><div> <div> Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. , /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Centessa Pharmaceuticals plc (NASDAQ: CNTA)'s sale to Eli Lilly and Company for $38.00 in cash per share plus one non-transferrable contingent value right entitling the holder to receive up to an aggregate of $9.00 subject to the achievement of certain milestones. If you are a Centessa shareholder, click here to learn more about your legal rights and options. KORE Group Holdings, Inc. (NYSE: KORE)'s sale to Searchlight Capital Partners, L.P. and Abry Partners for $9.25 per share. If you are a KORE shareholder, click here to learn more about your rights and options. Clearwater Analytics Holdings, Inc. (NYSE: CWAN)'s sale to Permira and Warburg Pincus for $24.55 per share in cash. If you are a Clearwater shareholder, click here to learn more about your rights and options. On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits. Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Halper Sadeh LLC Daniel Sadeh, Esq. Zachary Halper, Esq. One World Trade Center 85th Floor New York, NY 10007 (212) 763-0060 [email protected] [email protected] https://www.halpersadeh.com SOURCE Halper Sadeh LLP <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDIwJk5ld3NJdGVtSWQ9TlkzODY0MyZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MjAxNjMzUFJfTkVXU19VU1BSX19fX19OWTM4NjQz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDIwJk5ld3NJdGVtSWQ9TlkzODY0MyZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MjAxNjMzUFJfTkVXU19VU1BSX19fX19OWTM4NjQz"/></div> </div></div>

CNTA

CWAN

KORE

ELIL

Halper Sadeh LLC is investigating Centessa Pharmaceuticals (NASDAQ: CNTA), KORE Group Holdings (NYSE: KORE), and Clearwater Analytics (NYSE: CWAN) for potential violations of federal securities laws and breaches of fiduciary duties. The firm is concerned that insiders may benefit financially at the expense of ordinary shareholders in proposed sales to Eli Lilly, Searchlight Capital Partners, and Permira, respectively. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost.

16:33 ETAre CNTA, KORE, CWAN Obtaining Fair Deals for their Shareholders?